Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Hoel A, Olsboe S, Davidson J, Mutanen A, Granström A, Wong C, Beltman L, Wong K, Chung P, Tam P, van Heurn E, De Coppi P, Wester T, Pakarinen M, Bjørnland K(2025) SYSTEMATIC REVIEW ON QUESTIONNAIRES REPORTING BOWEL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HIRSCHSPRUNG DISEASE J Pediatr Surg, 162418(in press) DOI 10.1016/j.jpedsurg.2025.162418, PubMed 40541661
Nilsen JA, Egeland A, Tandberg P, Darre-Næss O, Norvard ER, Hvattum S(2025) Underwater endoscopic submucosal dissection of a 20-cm-long circular rectosigmoid polyp Endoscopy, 57(S 01), E606-E607 DOI 10.1055/a-2610-2567, PubMed 40532913
Kjeldsen SE, Esler M, Jamerson KA, Egan B, Mancia G(2025) In Memoriam: Stevo Julius, MD, ScD Hypertension, 82(7), e110-e113 DOI 10.1161/HYPERTENSIONAHA.125.25152, PubMed 40532018